Axon Neuroscience Se is a biotechnology company based in Larnaca, Cyprus, specializing in the development of innovative therapeutic solutions for neurodegenerative diseases. The organization focuses on advancing research in the field of neuroscience, particularly targeting conditions such as Alzheimer's disease. By leveraging cutting-edge technology and scientific expertise, Axon aims to create effective treatments that address the underlying mechanisms of these complex disorders, contributing to improved patient outcomes and quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

11 Patents

#4 in Larnaca

#18 in Cyprus

#51,801 in the World

Larnaca, Cyprus

Axon Neuroscience Se

Forward Citations = 26

9 inventors:

Eva Kontseková (8 out of 8 patents)

Branislav Kovácech (7 out of 7 patents)

Norbert Zilka (5 out of 5 patents)

4. Michal Novak (4 out of 7 patents)

5. Michal Novák (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Axon Neuroscience Se. Retrieved from https://idiyas.com/company/axon-neuroscience-se

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]